| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 11/24/2005 | US20050261337 Substituted quinoline derivatives |
| 11/24/2005 | US20050261336 e.g. 8-hydroxy-2-[2-[3,4-dihydroxy-5-methoxyphenyl)ethenyl]]-7-quinoline carboxylic acid; HIV integrase inhibitors; AIDS, retroviral pathologies |
| 11/24/2005 | US20050261335 Carvedilol formulations |
| 11/24/2005 | US20050261334 Bis-pyridino containing compounds for the use in the treatment of CNS pathologies |
| 11/24/2005 | US20050261333 Inhibitors of the kinase Itk; 2-aryl-substituted derivatives of 6-substituted-3H-imidazo[4,5-b]pyridines; to treat allergic, autoimmune, inflammatory, proliferative and hyperproliferative diseases and immune-mediated diseases; 6,7-dichloro-2-[4-(2-morpholin-4-ylethoxy)phenyl]-3H-imidazo[4,5-b]pyridine |
| 11/24/2005 | US20050261332 Sulfonamides and uses thereof |
| 11/24/2005 | US20050261331 Substituted pyrrolopyridines |
| 11/24/2005 | US20050261330 Derivatives of 2,2,4-trisubstituted tetrahydrofuran an antifungal agents |
| 11/24/2005 | US20050261329 administering morphinan's such as 3-methoxy-17-allylmorphinan hydrobromide for prevention or treatment of viral infections, septic shock, organ damage, neurological and cardiovascular disorders, neurodegenerative diseases and cancers |
| 11/24/2005 | US20050261328 Pharmaceutical composition comprising beta-3-adrenoceptor-agonists and antimuscarinic agents |
| 11/24/2005 | US20050261327 2-(Bicyclo)alkylamino-derivatives as mediatores of chronic pain and inflammation |
| 11/24/2005 | US20050261326 Metabolites of ecteinascidin 743 |
| 11/24/2005 | US20050261325 Gamma-aminoamide modulators of chemokine receptor activity |
| 11/24/2005 | US20050261324 Pyrimidine hydantoin analogues which inhibit leukocyte adhesion mediated by VLA-4 |
| 11/24/2005 | US20050261323 Medical uses of novel carbamate-substituted pyrazolopyridine derivatives |
| 11/24/2005 | US20050261322 HIV integrase inhibitors |
| 11/24/2005 | US20050261321 Substituted organosulfur compounds and methods of using thereof |
| 11/24/2005 | US20050261320 Compounds and methods for the treatment of cancer |
| 11/24/2005 | US20050261319 Novel 2-amino-4-quinazolinones and 2-amino-4-oxoquinazolones as LXR nuclear receptor binding compounds with partial agonistic properties |
| 11/24/2005 | US20050261318 Protein kinase inhibitors |
| 11/24/2005 | US20050261317 Inhibitors of human phosphatidylinositol 3-kinase delta |
| 11/24/2005 | US20050261316 Treatment of nervous system disorders, asthma and Alzheimers disease |
| 11/24/2005 | US20050261315 tyrosine kinase inhibitors such as N-(3-tert-butylisoxazol-5-yl)-2-(4-(benzyloxy)phenyl)acetamide, used for treating and preventing conditions and diseases, such as cancer, hematologic malignancies, cardiovascular disease, inflammation or multiple sclerosis |
| 11/24/2005 | US20050261313 For angiogenesis mediated diseases; cancer; acylation, cyclization and Heck-type reduction |
| 11/24/2005 | US20050261312 Pharmaceutically acceptable inorganic and organic salts of 5-methylpyrazine-2-carboxylic acid-4-oxide |
| 11/24/2005 | US20050261310 Piperazinylpiperidine derivatives as chemokine receptor antagonists |
| 11/24/2005 | US20050261309 Imidazole compounds |
| 11/24/2005 | US20050261307 administering fibroblast growth factor receptor 3 (FGFR3) inhibitors such as 4-amino-5-fluoro-3-[5-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl]quinolin-2(1H)-one, for the treatment of bone disorders in patient with a t(4;14) chromosomal translocation |
| 11/24/2005 | US20050261306 Anti-neurodegenerative agents |
| 11/24/2005 | US20050261305 Cyclic protein tyrosine kinase inhibitors |
| 11/24/2005 | US20050261304 1,3-benzothiazol-2-yl[2-({4-[(4-methylpiperazin-1-yl)methyl]benzyl}oxy)pyrimidin-4-yl]acetonitrile; crosses the Blood brain barrier |
| 11/24/2005 | US20050261302 Inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme and their therapeutic application |
| 11/24/2005 | US20050261301 e,g, 1,5-bis(5-acetyl-4,7-dimethoxybenzofuran-6-yloxy)pentane;potassium channel modulator; antiinflammatory agent, autoimmune diseases; immunosuppressant; multiple sclerosis, rejection of foreign organ transplants |
| 11/24/2005 | US20050261300 Liquid pharmaceutical formulations containing 3.7-diazabicyclo[3,3,1]nonane compounds and methods of treatment relating to arrhythmic events |
| 11/24/2005 | US20050261299 e.g. 4-((5-(6-methylpyridin-2-yl)-4-(quinoxalin-6-yl)-1(3)H-imidazol-2-yl)methyl)benzamide; transforming growth factor- beta (TGF- beta ) type I receptor (ALK5) and/or the activin type I receptor (ALK4) antagonist; wound healing agent, antidiabetic, anticarcinogenic, antiinflmmatory agent |
| 11/24/2005 | US20050261298 Methods of treating conditions associated with an Edg-7 receptor |
| 11/24/2005 | US20050261296 Indole, azaindole and related heterocyclic N-substituted piperazine derivatives |
| 11/24/2005 | US20050261294 Substituted heteroaryl derivatives, compositions, and methods of use |
| 11/24/2005 | US20050261293 Compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 11/24/2005 | US20050261292 Pharmaceutical composition containing N-sulfamoyl-N'-arylpiperazines for the treatment or inhibition of obesity and related conditions |
| 11/24/2005 | US20050261291 1-Cyclopropylmethyl-4-[2-(3,3,5,5-tetramethylcyclohexyl)phenyl]piperazine or a salt or hydrate; exhibit excellent cell adhesion inhibitory action or cell infiltration inhibitory action; for treating inflammatory diseases and autoimmune diseases such as inflammatory bowel diseases and rheumatoid arthritis |
| 11/24/2005 | US20050261290 Novel compounds of proline and morpholine derivatives |
| 11/24/2005 | US20050261288 Tetracyclic lactam derivatives and uses thereof |
| 11/24/2005 | US20050261287 Lactam-containing compounds and derivatives thereof as factor Xa inhibitors |
| 11/24/2005 | US20050261286 Substituted cycloalkyl derivatives, process for the manufacture thereof and use thereof as medicament |
| 11/24/2005 | US20050261285 Tetrahydropyran derivatives and their use as therapeutic agents |
| 11/24/2005 | US20050261283 Methods and compositions for the treatment of graft failure |
| 11/24/2005 | US20050261282 Treatment of basal ganglia-related movement disorders with 2,3-benzodiazepines |
| 11/24/2005 | US20050261281 Pharmaceutical compounds |
| 11/24/2005 | US20050261280 Stabilized antihistamine syrup |
| 11/24/2005 | US20050261279 antipsychotic agents; phenylsulfonyl compounds; 7-Methoxy-8-(3-phenoxy-benzenesulfonyl)-2,3,4,5-tetrahydro-1H-3-benzazepine; schizophrenia |
| 11/24/2005 | US20050261278 Selective serotonin receptor inverse agonists as therapeutics for disease |
| 11/24/2005 | US20050261277 Pentacyclic oxepines and derivatives thereof, compositions and methods |
| 11/24/2005 | US20050261275 Therapeutic combination |
| 11/24/2005 | US20050261274 1-[3-Methyl-1-(5-methyl-6-oxo-benzo[b]-1,4-diazepin-7-ylcarbamoyl)-butyl]-cyclohexanecarboxylic acid amide; inhibit processing of amyloid precursor protein (production of A beta -peptide); neurological disorders related to beta -amyloid production: Alzheimer's disease, Down's Syndrome |
| 11/24/2005 | US20050261273 Substituted urea and carbamate, phenacyl-2-hydroxy-3-diaminoalkane, and benzamide-2-hydroxy-3-diaminoalkane aspartyl-protease inhibitors |
| 11/24/2005 | US20050261272 Pyrrolopyridine-2-carboxylic acid amide inhibitors of glycogen phosphorylase |
| 11/24/2005 | US20050261271 Dipeptidyl peptidase inhibitors |
| 11/24/2005 | US20050261269 New derivatives of amidines, their preparation, their use as medicaments and the pharmaceutical compositions containing them |
| 11/24/2005 | US20050261267 Pharmaceutical formulation |
| 11/24/2005 | US20050261266 Apomorphine derivatives; radioimaging agents upon incorporation of radionuclides; neuronal function diagnosis |
| 11/24/2005 | US20050261262 Rifamycin derivatives effective against drug-resistant microbes |
| 11/24/2005 | US20050261261 Eplerenone drug substance having high phase purity |
| 11/24/2005 | US20050261260 Combination of a CDK inhibitor and mitoxantrone |
| 11/24/2005 | US20050261259 Phytosterol and/or phytostanol derivatives |
| 11/24/2005 | US20050261258 contacting localized fat deposits associated with cellulite in a patient with an effective amount of up to 5% deoxycholic acid or sodium salt of deoxychloic acid and an excipient; do not require surgical procedures such as liposuction; does not include phosphatidyl choline |
| 11/24/2005 | US20050261257 Compositions for treating or preventing cardiovascular disease |
| 11/24/2005 | US20050261256 Treatment of ICU-associated hypocalcemia with vitamin D compounds |
| 11/24/2005 | US20050261255 Use of docosatrienes, resolvins and their stable analogs in the treatment of airway diseases and asthma |
| 11/24/2005 | US20050261254 Carotenoid analogs or derivatives for the inhibition and amelioration of inflammation |
| 11/24/2005 | US20050261253 Pharmacokinetics; bioavailability |
| 11/24/2005 | US20050261252 LPA receptor agonists and antagonists and methods of use |
| 11/24/2005 | US20050261251 Antiviral agents and methods of treating viral infections |
| 11/24/2005 | US20050261250 Compositions and methods for inhibiting bone resorption |
| 11/24/2005 | US20050261248 New-4-pyrrolopyrimidin-6-YL)benzenesulphonamide derivatives |
| 11/24/2005 | US20050261247 Administering to mammal an inhibitor of NH2-terminal Jun Kinase (JNK), for therapy of metabolic disorder associated with insulin resistance |
| 11/24/2005 | US20050261246 Methods for treating inflammatory and autoimmune diseases |
| 11/24/2005 | US20050261245 Nitric oxide releasing prodrugs of diaryl-2-(5h)-furanones as cyclooxygenase-2 inhibitors |
| 11/24/2005 | US20050261244 Urea antagonists of P2Y1 receptor useful in the treatment of thrombotic conditions |
| 11/24/2005 | US20050261243 Antiprostaglandins for the treatment of ocular pathologies |
| 11/24/2005 | US20050261242 nitroso derivatives of drugs such as antiinflammatory agents, antibiotics, expectorants, mucolytic agents, antidiabetics, antitumor, viricides, enzyme inhibitors bronchodilators and antiulcer agents; oxidative and endothelial stress dysfunction; free radicals scavenger |
| 11/24/2005 | US20050261241 Use of dermatan sulfates and/or desulfated heparins to treat or prevent heparinoid-induced autoimmune responses |
| 11/24/2005 | US20050261240 Carrageenan based antimicrobial compositions |
| 11/24/2005 | US20050261239 Use of ATP for the manufacture of a medicament for treating certain inflammatory conditions, oxidative stress and fatigue |
| 11/24/2005 | US20050261238 Method for increasing muscle mass and strength through administration of adenosine triphosphate |
| 11/24/2005 | US20050261237 Nucleoside phosphonate analogs |
| 11/24/2005 | US20050261236 Agonists of A2A adenosine receptors for treatment of diabetic nephropathy |
| 11/24/2005 | US20050261231 Improving tissue survival; methods for enhancing organ transplant, musculocutaneous flap or skin graft survival by administering a nucleic acid sequence encoding hepatocyte growth factor; neovascularization; surgery; tissue-targeted therapy |
| 11/24/2005 | US20050261222 Oligoribonucleotides for the treatment of irritative or inflammatory skin symptoms through RNA interference |
| 11/24/2005 | US20050261215 Methods and immune modulatory nucleic acid compositions for preventing and treating disease |
| 11/24/2005 | US20050261210 Nonsense suppressor agents in treatment of cutaneous and gastrointestinal disorders |
| 11/24/2005 | US20050261209 Method of treating or preventing immune mediated disorders and pharmaceutical formulation for use therein |
| 11/24/2005 | US20050261208 Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with an anti-IgE antibody for treatment of asthma or chronic obstructive pulmonary disease |
| 11/24/2005 | US20050261207 Glucose-based compounds with affinity to p-selectin |
| 11/24/2005 | US20050261206 chemical intermediates to derivatives such as 3-(beta -D-Glucopyranosyloxy)-4-[(4-isopropoxyphenyl)methyl]-1-isopropyl-5-methylpyrazole; treatment of diabetes or obesity; inhibit SGLT2 (Na+/glucose cotransporter 2) |
| 11/24/2005 | US20050261205 Glucopyranosyloxypyrazole derivatives, medicinal compositions containing the same and intermediates in the production thereof |
| 11/24/2005 | US20050261204 administering to the subject the compound (R)-2-acetamido-N-benzyl-3-methoxypropionamide |
| 11/24/2005 | US20050261203 Azabicyclo-octane inhibitors of IAP |
| 11/24/2005 | US20050261201 Method of reducing C-reactive protein using growth hormone secretagogues |
| 11/24/2005 | US20050261197 Coffee bean extract, method of extraction and composition containing the same |